TY - JOUR T1 - Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection JF - J Gastroenterol Y1 - 2019 A1 - Naganuma, A A1 - Chayama, K A1 - Notsumata, K A1 - et, al VL - 54 SP - 752-761 IS - 8 ER -